Spherix’s coverage of the migraine market tracks the impact of expanding therapeutic choice on migraine management. Broad coverage of both the acute and preventive segments allows Spherix to assess the interplay of market dynamics for the treatment of episodic and chronic migraine.
Trending market evolution
Migraine (US) - quarterly, n=100
Exploring the patient journey
Acute Treatment Switching in Migraine (US) - annual, n=1,000 patient charts
Preventive Treatment Switching in Migraine (US) - annual, n=1,000 patient charts